The largest database of trusted experimental protocols

5 protocols using siglech ebio440c

1

Multicolor Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with a combination of biotinylated, FITC-, PE-, PE-Cy7, allophycocyanin-, allophycocyanin-eFluor780-, allophycocyanin-Cy7-, Brilliant Violet 421-, Brilliant Violet 786-, Pacific Blue-, Brilliant Violet 605-, Pacific Orange-, PerCPVio700, or PerCP-Cy5.5-conjugated monoclonal antibodies. The anti-CD45.1 (clone A20), CD45.2 (104), F4/80 (BM8), CD11c (HL3 or N418), CD11b (M1/70), B220 (RA3-6B2), CD24 (M1/69), CD172α (P84), CD80 (16-10A1), CD86 (GL1), MHC II (OX-6 or m5/114), CD3 (1145-2C11 or 500A2), CD19 (1D3), NKP46 (29A1.4), CD135 (A2F10.1), CCR7 (4B12), XCR1 (ZET), Ly6G (1A8), CD19 (1D3), CD90.2 (53-2.1), CD64 (X54-5/7.1), CCR9 (REA943), SiglecH (eBio440c), PDCA-1 (eBio927), and ESAM (REA722) antibodies were from eBioscience, BD Biosciences, or Miltenyi Biotec. Events were collected within a lymphoid gate based on forward-scatter (FSC) and side-scatter (SSC) profiles, and dead cells were excluded using propidium iodide or Fixable Viability Dye staining. Data were acquired on a BD LSRFortessa™ flow cytometer (BD Biosciences). Data were analyzed using BD FACSDiva™ software (BD Biosciences) or FlowJo software (Tree-star).
+ Open protocol
+ Expand
2

Flow Cytometry Analysis of Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry analysis and cell sorting of MPPs, CDPs, cDCs, and pDCs was performed as described previously 28 (link). Amplified progenitor cells were deprived of Flt3L for 1.5–2 h and stained for Flt3, c-kit, and Gr1. MPPs and CDPs were defined as Gr1Flt3−/loc-kithi and Gr1Flt3+c-kitint, respectively. Gating strategy for MPPs and CDPs is shown in Supporting Information Figure 1C. DCs were stained for CD11c, CD11b, and B220. cDCs were identified as CD11c+CD11bhiB220lo whereas pDCs were defined as CD11c+CD11bloB220hi. Gating strategy for cDCs and pDCs is shown in Supporting Information Fig. 3A. Flow cytometry and cell sorting were performed on a FACSCanto II and FACSAria I device, respectively (BD Biosciences). Sorted cells were either directly cross-linked for ChIP or lysed for RNA isolation. The following antibodies were used: Flt3 (CD135, A2F10), c-kit (CD117, ACK2), CD11c (N418), CD11b (M1/70), B220 (RA3–6B2), SiglecH (eBio440c) (all from eBioscience), and Gr1 (RB6–8C5) (BD Biosciences).
+ Open protocol
+ Expand
3

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell splenocyte suspensions were prepared and stained in ice-cold PBS with Ghost Dye Violet 510 (Tonbo Biosciences, San Diego, CA) to exclude dead cells. Surface staining was subsequently performed in PBS containing 3% FCS and 5 mM EDTA in the presence of unconjugated anti-CD16/32 clone 2.4G2 (purified in-house). Antibody clones used for staining were directed against CD45R (RA3-6B2), CD23 (B3B4), CD19 (1D3), CD11c (HL3) and TCRß (H57-597) (BD Biosciences, Franklin Lakes, NJ); CD62L (Mel-14), CD138 (281–2), CD11b (M1/70), TCRß (H57-597) and I-A/I-E (M5/114.15.2) (BioLegend, San Diego, CA); SiglecH (eBio440c) (eBioScience, San Diego, CA); and Ly6G (1A8), CD45R (RA3-6B2), CD19 (1D3), CD21/35 (7G6), CD317 (927), CD44 (Pgp1), CD8 (TIB105), and CD4 (GK1.5) (purified and fluorophore-conjugated in-house). Peanut agglutinin (PNA) was from Vector Laboratories (Burlingame, CA). All antibodies and PNA were titered prior to experimental use. Cells were fixed with 1xPBS 1% paraformaldehyde. Flow cytometry data was collected on a BD LSRII or BD Fortessa and analyzed in FlowJo (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
4

Multicolor Flow Cytometry for Dendritic Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
For FACS analysis as well as FACS sorting of single-cell suspensions, cells were first incubated with CD16/CD32-specific antibody (2.4G2; BD) for 10 min to block non-specific Fc-receptor interactions. A live death staining was performed using zombie aqua (eBioscience) according to the manufacturer’s instructions. To differentiate between DC subsets, cells were stained for 15 min at 4°C with combinations of antibodies specifically binding to CD11b (M1/70.15; Invitrogen), CD11c (HL3; BD), Siglec-H (eBio440c; eBioscience), CD69 (H1.2F3; BD), Clec9a (42D2; eBioscience), CD172 (SIRPα) (P84; Biolegend) and CD24 (M1/69; Biolegend). The cells were subsequently washed with 1 mL FACS buffer (PBS, 1% FCS) and then re-suspended in FACS buffer supplemented with 3% paraformaldehyde (PFA). Samples were measured using a FACS LSR II, and data were analyzed with FlowJo 7.6.5 software (TreeStar). Dead cells as well as cell duplets were excluded prior to subsequent analysis. DC subsets were sorted using the FACS Aria or FACS XDP and sorting efficiency ranged between 71.9–86.2% for the pDC, 81.4–94.4% for the CD11b-like DC and 44.54–83.2% for the CD8α-like DC.
+ Open protocol
+ Expand
5

Isolation and Characterization of Murine BMDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDCs were obtained by flushing bone marrow of femurs and tibias of CF-1 mice as previously described with minor modifications74 (link). Cells were plated at 1 × 106/ml with RPMI 1640 supplemented with 5% heat-inactivated fetal bovine serum, 100 U/ml penicillin/streptomycin, 10 μg/ml gentamicin and 2 mM l-glutamine, (all from Thermo Fisher) and in presence of 100 ng/ml Flt3L (R&DSystems) at 37 °C in 5% CO2 for 6 days. Finally, DC-population was characterized by flow cytometry using fluorescence-conjugated monoclonal antibodies (mAb) directed against CD11c (HL3), Flt3 (A2F10), Clec9a (42D2), CD172a (P84), CD11b (M1/70), CD3 (145-2C11), CD45R/B220 (RA3-6B2), SiglecH (eBio440c), and CD24 (M1/69) (eBiosciences). Approximately 70–80% of the cells were CD11c+.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!